Proof-of-Concept Gene Editing for the Murine Model of Inducible Arginase-1 Deficiency
Abstract Arginase-1 deficiency in humans is a rare genetic disorder of metabolism resulting from a loss of arginase-1, leading to impaired ureagenesis, hyperargininemia and neurological deficits. Previously, we generated a tamoxifen-inducible arginase-1 deficient mouse model harboring a deletion of...
Main Authors: | Yuan Yan Sin, Phillipe R. Price, Laurel L. Ballantyne, Colin D. Funk |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2017-05-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-017-02927-2 |
Similar Items
-
Transplantation of Gene-Edited Hepatocyte-like Cells Modestly Improves Survival of Arginase-1-Deficient Mice
by: Yuan Yan Sin, et al.
Published: (2018-03-01) -
Strategies to rescue the consequences of inducible arginase-1 deficiency in mice.
by: Laurel L Ballantyne, et al.
Published: (2015-01-01) -
Arginase impairs hypoxic pulmonary vasoconstriction in murine endotoxemia
by: Bodil Petersen, et al.
Published: (2019-06-01) -
Arginase-II Deficiency Extends Lifespan in Mice
by: Yuyan Xiong, et al.
Published: (2017-09-01) -
Plasma arginine levels in arginase deficiency in the “real world”
by: Pranoot Tanpaiboon, et al.
Published: (2024-03-01)